Arcadia Biosciences (RKDA) Current Leases (2019 - 2025)
Arcadia Biosciences' Current Leases history spans 7 years, with the latest figure at $11000.0 for Q2 2025.
- For Q2 2025, Current Leases fell 98.05% year-over-year to $11000.0; the TTM value through Jun 2025 reached $11000.0, down 98.05%, while the annual FY2024 figure was $155000.0, 81.81% down from the prior year.
- Current Leases reached $11000.0 in Q2 2025 per RKDA's latest filing, down from $21000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.1 million in Q3 2021 to a low of $11000.0 in Q2 2025.
- Average Current Leases over 5 years is $754500.0, with a median of $943000.0 recorded in 2021.
- Peak YoY movement for Current Leases: soared 62.0% in 2021, then tumbled 98.05% in 2025.
- A 5-year view of Current Leases shows it stood at $1.1 million in 2021, then decreased by 5.96% to $1.0 million in 2022, then fell by 15.64% to $852000.0 in 2023, then tumbled by 81.81% to $155000.0 in 2024, then plummeted by 92.9% to $11000.0 in 2025.
- Per Business Quant, the three most recent readings for RKDA's Current Leases are $11000.0 (Q2 2025), $21000.0 (Q1 2025), and $155000.0 (Q4 2024).